232 related articles for article (PubMed ID: 34134742)
21. Exclusion of serum- and glucocorticoid-induced kinase 1 (SGK1) as a candidate gene for genetically heterogeneous renal pseudohypoaldosteronism type I in eight families.
Riepe FG; Holterhus PM
Am J Nephrol; 2007; 27(2):164-9. PubMed ID: 17317952
[TBL] [Abstract][Full Text] [Related]
22. Pseudohypoaldosteronism in a newborn male with functional polymorphisms in the mineralocorticoid receptor genes.
Jeong HA; Park YK; Jung YS; Nam MH; Nam HK; Lee KH; Rhie YJ
Ann Pediatr Endocrinol Metab; 2015 Dec; 20(4):230-4. PubMed ID: 26817011
[TBL] [Abstract][Full Text] [Related]
23. A novel nonsense mutation of the mineralocorticoid receptor gene in the renal form of pseudohypoaldosteronism type 1.
Uchida N; Shiohara M; Miyagawa S; Yokota I; Mori T
J Pediatr Endocrinol Metab; 2009 Jan; 22(1):91-5. PubMed ID: 19344080
[TBL] [Abstract][Full Text] [Related]
24. Renin-aldosterone response, urinary Na/K ratio and growth in pseudohypoaldosteronism patients with mutations in epithelial sodium channel (ENaC) subunit genes.
Hanukoglu A; Edelheit O; Shriki Y; Gizewska M; Dascal N; Hanukoglu I
J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):268-74. PubMed ID: 18634878
[TBL] [Abstract][Full Text] [Related]
25. Identification of a novel mutation in the human mineralocorticoid receptor gene in a german family with autosomal-dominant pseudohypoaldosteronism type 1: further evidence for marked interindividual clinical heterogeneity.
Riepe FG; Krone N; Morlot M; Ludwig M; Sippell WG; Partsch CJ
J Clin Endocrinol Metab; 2003 Apr; 88(4):1683-6. PubMed ID: 12679457
[TBL] [Abstract][Full Text] [Related]
26. A novel nonsense mutation of the mineralocorticoid receptor gene in a Swedish family with pseudohypoaldosteronism type I (PHA1).
Nyström AM; Bondeson ML; Skanke N; Mårtensson J; Strömberg B; Gustafsson J; Annerén G
J Clin Endocrinol Metab; 2004 Jan; 89(1):227-31. PubMed ID: 14715854
[TBL] [Abstract][Full Text] [Related]
27. Systemic pseudohypoaldosteronism-1 with episodic dyslipidemia in a Sudanese child.
Abdalla A; Alhassan MA; Tawfeeg R; Sanad A; Tawamie H; Abdullah M
Endocrinol Diabetes Metab Case Rep; 2021 Jun; 2021():. PubMed ID: 34165441
[TBL] [Abstract][Full Text] [Related]
28. Novel mutations responsible for autosomal recessive multisystem pseudohypoaldosteronism and sequence variants in epithelial sodium channel alpha-, beta-, and gamma-subunit genes.
Saxena A; Hanukoglu I; Saxena D; Thompson RJ; Gardiner RM; Hanukoglu A
J Clin Endocrinol Metab; 2002 Jul; 87(7):3344-50. PubMed ID: 12107247
[TBL] [Abstract][Full Text] [Related]
29. A novel mutation of the epithelial Na+ channel causes type 1 pseudohypoaldosteronism.
Bonny O; Knoers N; Monnens L; Rossier BC
Pediatr Nephrol; 2002 Oct; 17(10):804-8. PubMed ID: 12376807
[TBL] [Abstract][Full Text] [Related]
30. An unusual case of Pseudohypoaldosteronism coexisting with cystic fibrosis.
Umapathy N; Thirugnana Sambanda Moorthy B; Azhagar Nambi Santhi V; Nair LDV
BMJ Case Rep; 2024 Jun; 17(6):. PubMed ID: 38914525
[TBL] [Abstract][Full Text] [Related]
31. Evidence for genetic heterogeneity of pseudohypoaldosteronism type 1: identification of a novel mutation in the human mineralocorticoid receptor in one sporadic case and no mutations in two autosomal dominant kindreds.
Viemann M; Peter M; López-Siguero JP; Simic-Schleicher G; Sippell WG
J Clin Endocrinol Metab; 2001 May; 86(5):2056-9. PubMed ID: 11344206
[TBL] [Abstract][Full Text] [Related]
32. Pseudohypoaldosteronisms, report on a 10-patient series.
Belot A; Ranchin B; Fichtner C; Pujo L; Rossier BC; Liutkus A; Morlat C; Nicolino M; Zennaro MC; Cochat P
Nephrol Dial Transplant; 2008 May; 23(5):1636-41. PubMed ID: 18424465
[TBL] [Abstract][Full Text] [Related]
33. Clinical and molecular analysis of six Japanese patients with a renal form of pseudohypoaldosteronism type 1.
Hatta Y; Nakamura A; Hara S; Kamijo T; Iwata J; Hamajima T; Abe M; Okada M; Ushio M; Tsuyuki K; Tajima T
Endocr J; 2013; 60(3):299-304. PubMed ID: 23197115
[TBL] [Abstract][Full Text] [Related]
34. Clinical Management in Systemic Type Pseudohypoaldosteronism Due to
Karacan Küçükali G; Çetinkaya S; Tunç G; Oğuz MM; Çelik N; Akkaş KY; Şenel S; Güleray Lafcı N; Savaş Erdeve Ş
J Clin Res Pediatr Endocrinol; 2021 Nov; 13(4):446-451. PubMed ID: 32840096
[TBL] [Abstract][Full Text] [Related]
35. A novel splice-site mutation in the gamma subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families.
Strautnieks SS; Thompson RJ; Gardiner RM; Chung E
Nat Genet; 1996 Jun; 13(2):248-50. PubMed ID: 8640238
[TBL] [Abstract][Full Text] [Related]
36. Salt-Losing Syndrome in a Girl with Type I and II Pseudohypoaldosteronism.
Szmigielska A
Am J Case Rep; 2022 Oct; 23():e937536. PubMed ID: 36303414
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics and treatment requirements of children with autosomal recessive pseudohypoaldosteronism.
Bandhakavi M; Wanaguru A; Ayuk L; Kirk JM; Barrett TG; Kershaw M; Högler W; Shaw NJ
Eur J Endocrinol; 2021 May; 184(5):K15-K20. PubMed ID: 33690157
[TBL] [Abstract][Full Text] [Related]
38. Pseudohypoaldosteronism type 1 due to novel variants of SCNN1B gene.
Nobel YR; Lodish MB; Raygada M; Rivero JD; Faucz FR; Abraham SB; Lyssikatos C; Belyavskaya E; Stratakis CA; Zilbermint M
Endocrinol Diabetes Metab Case Rep; 2016; 2016():150104. PubMed ID: 26807262
[TBL] [Abstract][Full Text] [Related]
39. Mineralocorticoid resistance.
Zennaro MC; Lombès M
Trends Endocrinol Metab; 2004 Aug; 15(6):264-70. PubMed ID: 15358279
[TBL] [Abstract][Full Text] [Related]
40. Systemic pseudohypoaldosteronism from deletion of the promoter region of the human Beta epithelial na(+) channel subunit.
Thomas CP; Zhou J; Liu KZ; Mick VE; MacLaughlin E; Knowles M
Am J Respir Cell Mol Biol; 2002 Sep; 27(3):314-9. PubMed ID: 12204893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
